~~SECURITIES~~Securities ~~AND~~and ~~EXCHANGE~~Exchange ~~COMMISSION~~Commission Washington, D.C. 20549

~~FORM~~ Form 8-K

~~CURRENT REPORT PURSUANT~~Current TOReport ~~SECTION~~Pursuant to Section 13 ORor 15(d) of ~~OF THE SECURITIES~~the ~~EXCHANGE~~Securities ~~ACT~~Exchange OFAct of 1934

Date of Report (Date of Earliest Event Reported): ~~November 4~~March 1, ~~2001~~ 2003

~~DIALOG~~Dialog ~~GROUP~~Group, ~~INC~~Inc. (Exact name of Registrant as specified in its charter) ~~(formerly IMX Pharmaceuticals, Inc.)~~

Commission File Number 000–-30294

Delaware	87-0394290
(State or other jurisdiction of incorporation or organization	(I.R.S. Employer Identification No.)

~~Third~~Twelfth Floor, 17257 ~~State~~Park ~~Street~~Avenue South, New York, NY ~~10004~~10010 (Address of Principal Executive Offices)

212~~.509.9500 (Registrant's~~-254-1917 ~~Telephone number, including area code)~~

~~Page~~(Registrant's 1Telephone ofnumber, 5including area code)

Page 1 of 1

Back to Contents

ITEM 2. Acquisition or Disposition of Assets.

OnEffective ~~November~~March ~~6th~~1, ~~2002~~2003, Registrant, Dialog Group, Inc. (“~~IMX~~DGI”), ~~entered~~completed ~~into an Agreement for Merger (~~the ~~“Agreement”),~~merger ~~with Healthcare~~of HealthCare Dialog, Inc. ~~(“HCD”).~~and ~~Pursuant~~IP2M, toInc. into ~~the Agreement~~separate, ~~HCD~~wholly ~~will~~owned ~~merge with an IMX subsidiary~~subsidiaries.

Healthcare Dialog Acquisition

~~When~~On ~~the~~November ~~merger is consummated~~6th, ~~IMX will issue its Common~~2002, ~~Class~~Registrant ~~B-1~~(“IMX”) ~~Preferred,~~entered ~~Class~~into Can ~~Preferred~~Agreement ~~Stock,~~for ~~and~~Merger ~~warrants~~(the ~~to purchase its Common Stock~~“Agreement”), sowith ~~that~~Healthcare ~~the~~Dialog, ~~former~~Inc. ~~shareholders of~~ (“HCD”). ~~will~~On ~~own~~February ~~one half of each type of security.~~27th, ~~After~~2003, the ~~conclusion~~Agreement ofwas ~~this~~amended ~~transaction~~and ~~Peter DeCrescenzo will hold approximately 30% of~~ the ~~equity~~merger ofwas ~~IMX~~consummated. AsIt abecame ~~result, he will join Stephen Dean, IMX’s Chairman as a~~effective ~~controlling~~on ~~person~~March ~~of IMX. It is anticipated that after the consummation of the Merger~~1, ~~Mr. DeCrescenzo will become President and CEO of IMX.~~ 2003

~~The~~Description ~~consummation~~ of ~~the merger is subject to several conditions,~~Healthcare ~~principally~~ Dialog, ~~the conclusion of a $1 million net financing~~Inc. (HCD)

Healthcare Dialog, Inc. is a leading provider of relationship marketing communications services to the healthcare industry. Healthcare Dialog provides pharmaceutical companies with a suite of integrated healthcare-specific campaign creation and management capabilities - including strategic and creative services, interactive communication services, patient/consumer target identification, and database enhancement and management services. Combining these services into 5ntergrated programs, Healthcare Dialog creates, launches, and continually upgrades a wide range of targeted and highly customizable direct and interactive marketing campaigns. Clients rely on Healthcare Dialog to help establish and build more valuable and longer lasting relationships with physicians, patients, and consumers over a broad array of permission-based contact points, including Internet websites, opt-in e-mails, digital, on-demand print, direct mail and telemarketing. Healthcare Dialog provides clients with comprehensive healthcare expertise, access to databases of more than 100 million households, experience in scalable mass personalization distribution technology, capabilities in syndicated marketing campaigns and track record of successfully delivering professional results.

~~IMX~~Past ~~is a technology driven marketing~~ and ~~sales solutions~~present ~~Company~~Healthcare ~~that~~Dialog ~~provides~~clientele ~~direct~~includes ~~mail~~global ~~and~~pharmaceutical ~~telemarketing~~leaders ~~services~~such ~~through its~~as ~~wholly~~Novartis ~~owned~~AG ~~subsidiaries~~and ~~ThinkDirectMarketing, Inc~~Schering-Plough Corp. ~~(TDMI)~~ and ~~Findstar,~~healthcare ~~plc. TDMI~~product ~~designs,~~retailers ~~develops~~such ~~and~~as ~~distributes~~the ~~online~~Rite ~~products~~Aid ~~and~~drugstore ~~services that automate~~ chain. ~~and~~Healthcare ~~streamline~~Dialog ~~direct~~partners ~~marketing~~with ~~processes~~numerous ~~and~~client-side ~~provides~~brand teams ~~marketing~~ and sales ~~solutions for~~force ~~customer~~management ~~acquisition~~teams and ~~customer~~wide ~~retention~~ranging ~~for~~experience ~~small-~~with toboth ~~mid-size~~mass ~~companies. TDMI~~market ~~has~~and ~~developed~~niche aclient ~~scaleable~~brands, ~~and~~including ~~complementary~~such ~~line~~household ofnames ~~data~~as ~~management~~Allegra® ~~products~~ and ~~professional direct mail services~~Coppertone®. ~~TDMI partners include: United States Postal~~ ~~Service,~~Because ~~Microsoft,~~of ~~Avery~~it’s ~~Dennison,~~in-house ~~Acxiom,~~content ~~Claritas,~~development ~~Artisoft~~ and ~~Interactive Intelligence.~~media ~~Findstar~~production iscapabilities, aHealthcare ~~sales~~Dialog ~~led~~also ~~organization~~provides ~~with~~its ~~telemarketing~~services ~~capabilities currently~~to ~~responsible~~other ~~for~~industries, ~~the~~including ~~sale~~Insurance, Hotel and ~~distribution~~Hospitality ofServices, ~~Panda~~etc., ~~Software~~including ~~anti-virus software~~companies ~~and~~such ~~products~~as inAssurant, ~~the~~Progressive UKInsurance and ~~provides a platform for TDMI's launch~~Marriott ~~into~~Vacation ~~the UK and Europe.~~ Clubs

Description of ~~Healthcare~~the ~~Dialog~~Transaction

Upon consummation of the merger between Healthcare Dialog and a wholly owned subsidiary of DGI, the Registrant issued 30,075,219 shares of its Common and 183,235 shares of its Class B-1 Preferred to the present Healthcare Dialog shareholders. This is intended to equal the number of outstanding before the transaction plus an estimated number of shares that will be issued to complete DGI’s financing program.

~~Healthcare~~Page ~~Dialog,~~2 ~~Inc. is a leading provider~~ of relationship marketing communications services to the healthcare industry. Healthcare Dialog provides pharmaceutical companies with a suite of integrated healthcare-specific campaign creation and management capabilities – including strategic and creative services, interactive communication services, patient/consumer target identification, and database enhancement and management services. Combining these services, Healthcare Dialog creates, launches and continually upgrades a wide range of targeted and highly customizable direct and interactive marketing campaigns. Clients rely on Healthcare Dialog to help establish and build more valuable and longer lasting relationships with physicians, patients and consumers over a broad array of permission-based contact points, including Internet websites, opt-in e-mails, digital, on-demand print, direct mail and telemarketing. Healthcare Dialog provides clients with comprehensive healthcare expertise, access to databases of almost 100 million households, expertise in scalable mass personalization distribution technology, capabilities in syndicated marketing campaigns and track record of successfully delivering professional results. 2

~~Past~~Back and present Healthcare Dialog clientele includes pharmaceutical leaders such as Novartis AG and Schering-Plough Corp. and healthcare product retailers such as the Rite Aid drugstore chain. Healthcare Dialog partners with client-side brand teams and sales force management teams and wide ranging experience with both mass market and niche client brands, including such household names as Allegra® and Coppertone®. Because of its in-house content development and media production capabilities, Healthcare Dialog also provides its services to ~~other industries, including Insurance, Hotel and Hospitality Services, etc., including companies such as Assurant, Progressive Insurance and Marriott Vacation Clubs.~~Contents

~~Page~~The 2amended agreement calls for an additional $1,650,000 in financing. Cater Barnard has agreed to assure that at least $650,000 will be raised and has agreed to post negotiable collateral against its obligation to purchase up to 3,513,514 shares of 5DGI Common Stock.

~~ITEM~~IP2M ~~5. Other Events~~Acquisition

On December 23, 2002 DGI entered into a letter of intent relative to its proposed acquisition of IP2M, Inc. (“IP2M”). On February 24, 2003, DGI and IP2M concluded an Agreement for Merger providing that IP2M would merge with a subsidiary of DGI. The merger became effective March 1, 2003.

Description of IP2M

IP2M is a marketing company that has developed a unique marketing platform in healthcare that integrates radio, television, and the Internet to assist clients in targeting consumers. IP2M offers a national solution using the existing loyalty of the local radio and television stations to drive traffic to the client's content and advertising within the IP2M platform.

	IP2M offers its clients
	•	Specialized advertising, marketing, and promotional programs to targeted consumers at competitive rates
	•	Broad coverage through exclusive content partnerships with leading media companies (including Clear Channel Radio, Morris Communications, Nassau Media Partners, Hispanic Broadcasting, Granite Broadcasting Corp. and through Internet Broadcasting Systems (IBS) with Hearst Television, Post Newsweek Television, McGraw Hill Television, and Freedom Television.)
	•	Proprietary content and distribution technology.

Typically, IP2M will provide healthcare-related content to a media partners’ branded website and sell the entire “package” of radio, television and online media to its healthcare customers. Through its media partnerships, IP2M has immediate access to over 1,000 radio and television stations and an audience in excess of 100,000,000 people. Each of these radio and television stations is sending consumers to their websites. Thus, IP2M receives the benefit of its media partners’ existing website viewers. IP2M’s unique technology allows it to distribute different content and advertising to each site based on market and demographics in a scalable manner. Through its network of thousands of websites, radio and television stations, IP2M is able to reach and specifically target millions of consumers on a nation-wide basis and provide customization based on product and market segmentation. As IP2M integrates all media, it has become a “one stop shop” offering clients cost-efficiencies that they cannot find anywhere else in the $15 billion healthcare advertising market.

IP2M tracks results, supplies objective performance measures, and is able to maximize its clients’ return on investment. Clients have found IP2M’s health channel to be 5 times more effective than print media alone and 10 times more effective than the Internet without any broadcast support in directing viewers to the clients’ own website.

Page 3 of 3

Back to Contents

IP2M’s clients for 2002 included Roche Pharmaceutical, Pfizer, GlaxoSmithKline, Depuy Johnson & Johnson, Takeda Pharmaceuticals, Novartis, St Luke's Hospital and Quality Medical Management. Each client has extended its campaign, engaged IP2M for additional brands, or placed IP2M on its 2003 media plan.

Description of the Transaction

Upon consummation of the merger between IP2M and a wholly owned subsidiary of DGI, the Registrant issued 6,186,844 shares of its Common Stock and 44,267 shares of its Class B-1 Preferred to the present IP2M shareholders. This is intended to approximate ten (10%) percent of the number of shares of each class outstanding after these transactions. After the closing, the IP2M shareholders may share approximately 700,000 additional shares of Common Stock if certain financial goals are met. Also, please see “Additional Acquisitions” below for a description of possible further issuances to the IP2M shareholders. All the shares issued for the IP2M owners are held in escrow to secure the accuracy of their representations.

Corporate Control

Of the approximately 70,000,000 common shares which will be outstanding after the consummation of both transactions and the immediate anticipated financings, Stephen Dean controls approximately 25% of the Common Stock and 32% of the Preferred Stock. As a result of the transactions, Peter V. DeCrescenzo will hold approximately 26% Common Stock and 26% of the Preferred Stock of DGI. In addition, he has been appointed President and CEO. As a result, he has joined Stephen Dean, DGI’s Chairman, as a controlling person of DGI. The only other person known by DGI to own more than five (5%) percent of any class of security is Cindy Lanzendoen, DGI’s Senior Vice President and head of the HealthCare Dialog Division. Ms. Lanzendoen owns approximately six (6%) of the Common Stock and six (6%) percent of the Preferred Stock forecast to be outstanding.

The Agreement relating to the HealthCare Dialog merger required that the initial post merger Board of Directors consist of two people nominated by Stephen Dean and two by HealthCare Dialog, a company then controlled by Peter DeCrescenzo, as well as one person selected jointly. There are now four Directors, Stephen Dean, Peter V. DeCrescenzo, Vincent DeCrescenzo, Sr. and Adrian Stecyk. A fifth director is being sought.

Additional Acquisitions

DGI is negotiating to acquire the fifty (50%) percent of Healthcare Horizons, Inc. not now owned by DGI and the assets of Azimuth Target Marketing, Inc. The proposed acquisition price is 5,307,392 shares of Common Stock and 32,336 shares of Preferred Stock. If this transaction is consummated, the former IP2M shareholders will receive and additional 589,120 shares of Common Stock and 3,589 shares of Preferred Stock.

Page 4 of 4

Back to Contents

Description of DGI’s Current Subsidiaries

DGI provides direct mail and telemarketing services through its wholly owned subsidiary ThinkDirectMarketing, Inc. (TDMI) and virus protection software through Findstar, plc, its British subsidiary. TDMI designs, develops and distributes online products and services that automate and streamline direct marketing processes and provides marketing and sales solutions for customer acquisition and customer retention for small- to mid-size companies. TDMI has developed a scaleable and complementary line of data management products and professional direct mail services. TDMI partners include: United States Postal Service, Microsoft, Avery Dennison, Acxiom, Claritas, Artisoft and Interactive Intelligence. Findstar is a sales led organization with telemarketing capabilities currently responsible for the sale and distribution of Panda Software anti-virus software and products in the UK. It also provides a platform for TDMI’s, HCD’s, and IP2M’s launchs into the UK and Europe.

Debt Conversion

Immediately prior to these acquisitions, Cater Barnard exchanged $2,318,570 of DGI debt to it for 9,274,280 shares of DGI Common Stock.

ITEM 5. Creation of Additional Classes of Stock.

In anticipation of the acquisitions described above, DGI created two new classes of Preferred Stock, Classes B-1 and C. Only the B-1 was issued. No Class C is outstanding at this time and no issue is contemplated.

To provide collateral for an anticipated $1,500,000 loan, the DGI created a Class D Preferred Stock. 3,950 shares have been issued and are to be held in escrow. They do not have any voting rights and can be converted into Common Stock only upon the existence of an uncured default of the Loan.

ITEM 7. Financial Statements, Pro Forma Financial Information and Exhibits.

The historical pro forma financial ~~statements~~ statements required by Item 7 as a result of the transactions described in Item 2 will ~~not~~ be filed ~~until~~not ~~seventy-five~~later ~~days~~than ~~after~~May ~~the~~14th, ~~merger is consummated~~2003..

Exhibit Number		Description
3.10		Delaware Certificate of Merger between IMX Pharmaceuticals and Dialog Group Inc. (Incorporated by reference from Report on Form 10-Q for the quarter ended September 30, 2002 filed on November 15, 2002)
2.2		Amendment dated February 27, 2003 to an Agreement for Merger by and among IMX Pharmaceuticals, Inc., a Utah corporation (“IMX”) (for itself and for Dialog Group, Inc., its successor by merger), HCD Acquisition, Inc. (“HCD Acquisition”), a Delaware corporation, Healthcare Dialog, Inc., a Delaware corporation (“HCD”), and Peter V. DeCrescenzo, Vincent DeCrescenzo, Sr., and Cindy Lanzendoen, each an individual, (collectively, the “Shareholders”) and Cater Barnard, plc, an a corporation of England and Wales (“CB”).
10.5		Agreement for Merger dated November 6, 2002 among among IMX Pharmaceuticals, Inc., a Utah corporation (“IMX”) (for itself and for Dialog Group, Inc., its successor by merger), HCD Acquisition, Inc. (“HCD Acquisition”), a Delaware corporation, Healthcare Dialog, Inc., a Delaware corporation (“HCD”), and Peter DeCrescenzo, Vincent DeCrescenzo, and Cindy Lanzendoen, each an individual, (collectively, the “Shareholders”) and Stephen Dean, an individual (the “Guarantor”).

Page 35 of 5

Back to Contents

2.3		Agreement for Merger dated February 24, 2003 among Dialog Group, Inc., a Delaware corporation (“DGI”), IP2M Acquisition Corp. (“Acquisition”), a Delaware corporation, IP2M, Inc., a Delaware corporation (“IP2M”), and Robin Smith, William Donovan, Five Don, Ltd. (a/k/a 5 Don Ltd.), Cameron Bevis, and Art Sadin.

3(i).1		Amendment Creating the Class D Preferred Stock

3(i).2		Restated Certificate of Incorporation

3.(ii)		Revised By-Laws

Page 6 of 6

Back to Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	IMX PHARMACEUTICALS, INC.
	DIALOG GROUP, INC.
Date: November 11, 2002	By: /s/ Adrian Stecyk
Date: March 14, 2003	By:	/s/ Peter V. DeCrescenzo
	Adrian Stecyk, President
		Peter V. DeCrescenzo, President & CEO

Page 47 of 57

Back to Contents

INDEX TO EXHIBITS

Exhibit Number	Description	Page
10.5	Agreement for Merger dated November 6, 2002 among IMX Pharmaceuticals, Inc., a Utah corporation (“IMX”) (for itself and for Dialog Group, Inc., its successor by merger), HCD Acquisition, Inc. (“HCD Acquisition”), a Delaware corporation, Healthcare Dialog, Inc., a Delaware corporation (“HCD”), and Peter DeCrescenzo, Vincent DeCrescenzo, and Cindy Lanzendoen, each an individual, (collectively, the “Shareholders”) and Stephen Dean, an individual (the “Guarantor”).	1–19
2.2	Amendment dated February 27, 2003 to an Agreement for Merger by and among IMX Pharmaceuticals, Inc., a Utah corporation (“IMX”) (for itself and for Dialog Group, Inc., its successor by merger), HCD Acquisition, Inc. (“HCD Acquisition”), a Delaware corporation, Healthcare Dialog, Inc., a Delaware corporation (“HCD”), and Peter V. DeCrescenzo, Vincent DeCrescenzo, Sr., and Cindy Lanzendoen, each an individual, (collectively, the “Shareholders”) and Cater Barnard, plc, an a corporation of England and Wales (“CB”).
2.3	Agreement for Merger dated February 24, 2003 among Dialog Group, Inc., a Delaware corporation (“DGI”), IP2M Acquisition Corp. (“Acquisition”), a Delaware corporation, IP2M, Inc., a Delaware corporation (“IP2M”), and Robin Smith, William Donovan, Five Don, Ltd. (a/k/a 5 Don Ltd.), Cameron Bevis, and Art Sadin.
3(i).1	Restated Certificate of Incorporation
3(i).2	Amendment Creating the Class D Preferred Stock
3.(ii)	Revised By-Laws

Page 58 of 58

Filing Compare · DIALOG GROUP INC